Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion

FEBS Journal

Volumn 282, Issue 2, 2015, Pages 259-270

  Kim, Hyo Yeon ^a   Kim, Seok Joo ^a   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

inflammasome; interleukin 1 ; ischemia reperfusion; liver; reactive oxygen species

Indexed keywords

ABSENT IN MELANOMA 2; ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING CASPASE RECRUITMENT DOMAIN; CATHEPSIN B; CATHEPSIN B ANTIBODY; CRYOPYRIN; GADOLINIUM CHLORIDE; GLUTATHIONE; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PANNEXIN 1; PANNEXIN 1 INHIBITOR; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG; AIM2 PROTEIN, MOUSE; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; DNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPLETION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE SILENCING; IN VIVO STUDY; KUPFFER CELL; LIPID PEROXIDATION; LIVER CELL DAMAGE; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLOOD; GENETICS; HUMAN; IMMUNOLOGY; INJURIES; LIVER; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ACETYLCYSTEINE; ANIMALS; CARRIER PROTEINS; CATHEPSIN B; DNA-BINDING PROTEINS; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; KUPFFER CELLS; LIVER; MICE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 84924993872     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13123     Document Type: Article

References (47)

1. Wanner GA, Ertel W, Muller P, Hofer Y, Leiderer R, Menger MD, &, Messmer K, (1996) Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 5, 34-40.
2. Gonzalez EB, (2012) An update on the pathology and clinical management of gouty arthritis. Clin Rheumatol 31, 13-21.
3. Zhu P, Duan L, Chen J, Xiong A, Xu Q, Zhang H, Zheng F, Tan Z, Gong F, &, Fang M, (2011) Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Hum Gene Ther 22, 853-864.
4. Kamo N, Ke B, Ghaffari AA, Shen XD, Busuttil RW, Cheng G, &, Kupiec-Weglinski JW, (2013) ASC/caspase-1/IL-1beta signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 58, 351-362.
5. Martinon F, Petrilli V, Mayor A, Tardivel A, &, Tschopp J, (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241.
6. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, &, Tschopp J, (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677.
7. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, &, Tschopp J, (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452, 103-107.
8. Gurcel L, Abrami L, Girardin S, Tschopp J, &, van der Goot FG, (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135-1145.
9. Zhou R, Tardivel A, Thorens B, Choi I, &, Tschopp J, (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11, 136-140.
10. van de Veerdonk FL, Smeekens SP, Joosten LA, Kullberg BJ, Dinarello CA, van der Meer JW, &, Netea MG, (2010) Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci USA 107, 3030-3033.
11. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, et al,. (2009) Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183, 787-791.
12. Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F, Carlsson SK, Scemes E, Keane RW, &, Dahl G, (2009) The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem 284, 18143-18151.
13. Dvoriantchikova G, Ivanov D, Barakat D, Grinberg A, Wen R, Slepak VZ, &, Shestopalov VI, (2012) Genetic ablation of Pannexin1 protects retinal neurons from ischemic injury. PLoS One 7, e31991.
14. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, &, Latz E, (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9, 847-856.
15. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, &, Fitzgerald KA, (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518.
16. Hardonk MJ, Dijkhuis FW, Hulstaert CE, &, Koudstaal J, (1992) Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 52, 296-302.
17. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia Jda S, Ulevitch RJ, Hoffman HM, &, McKay DB, (2010) An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol 185, 6277-6285.
18. Osuka A, Hanschen M, Stoecklein V, &, Lederer JA, (2012) A protective role for inflammasome activation following injury. Shock 37, 47-55.
19. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, &, Tschopp J, (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14, 1583-1589.
20. Jaeschke H, &, Lemasters JJ, (2003) Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125, 1246-1257.
21. Sun X, Imai M, Nowak-Machen M, Guckelberger O, Enjyoji K, Wu Y, Khalpey Z, Berberat P, Munasinghe J, &, Robson SC, (2011) Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia. Purinergic Signal 7, 427-434.
22. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, &, Dixit VM, (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232.
23. Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, &, Nunez G, (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26, 433-443.
24. Franchi L, Kanneganti TD, Dubyak GR, &, Nunez G, (2007) Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 282, 18810-18818.
25. Pelegrin P, &, Surprenant A, (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25, 5071-5082.
26. Guicciardi ME, Miyoshi H, Bronk SF, &, Gores GJ, (2001) Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am J Pathol 159, 2045-2054.
27. Baskin-Bey ES, Canbay A, Bronk SF, Werneburg N, Guicciardi ME, Nyberg SL, &, Gores GJ, (2005) Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am J Physiol Gastrointest Liver Physiol 288, G396-G402.
28. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, &, Golenbock DT, (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9, 857-865.
29. Niemi K, Teirila L, Lappalainen J, Rajamaki K, Baumann MH, Oorni K, Wolff H, Kovanen PT, Matikainen S, &, Eklund KK, (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186, 6119-6128.
30. Davis BK, Wen H, &, Ting JP, (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29, 707-735.
31. Sagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, Vajjhala PR, Roberts TL, Schroder K, Vince JE, Hill JM, et al,. (2013) AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ 20, 1149-1160.
32. Chen GY, &, Nunez G, (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10, 826-837.
33. Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, &, DeMatteo RP, (2010) Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51, 621-632.
34. Huang H, Evankovich J, Yan W, Nace G, Zhang L, Ross M, Liao X, Billiar T, Xu J, Esmon CT, et al,. (2011) Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 54, 999-1008.
35. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, van der Meer JH, van de Veerdonk FL, Ferwerda G, Heinhuis B, Devesa I, et al,. (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113, 2324-2335.
36. Szabo G, &, Csak T, (2012) Inflammasomes in liver diseases. J Hepatol 57, 642-654.
37. Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, &, Szabo G, (2012) IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 122, 3476-3489.
38. Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, &, Seki E, (2013) Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57, 577-589.
39. Huang H, Chen HW, Evankovich J, Yan W, Rosborough BR, Nace GW, Ding Q, Loughran P, Beer-Stolz D, Billiar TR, et al,. (2013) Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J Immunol 191, 2665-2679.
40. Jaeschke H, &, Woolbright BL, (2012) Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando) 26, 103-114.
41. Jabaut J, Ather JL, Taracanova A, Poynter ME, &, Ckless K, (2013) Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1beta secretion in association with alterations in cellular redox and energy status. Free Radic Biol Med 60, 233-245.
42. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, &, Ojcius DM, (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282, 2871-2879.
43. Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, et al,. (2013) Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39, 311-323.
44. Zhang L, Deng T, Sun Y, Liu K, Yang Y, &, Zheng X, (2008) Role for nitric oxide in permeability of hippocampal neuronal hemichannels during oxygen glucose deprivation. J Neurosci Res 86, 2281-2291.
45. Windelborn JA, &, Lipton P, (2008) Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA-mediated calcium influx, arachidonic acid metabolism, and free radical production. J Neurochem 106, 56-69.
46. Oslowski C, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S, Hara M, Ishigaki S, Zhu L, Hayashi E, Hui S, et al,. (2012) Thioredoxin-interacting protein mediates ER stress-induced β Cell death through initiation of the inflammasome. Cell Metab 16, 265-273.
47. Meissner F, Seger RA, Moshous D, Fischer A, Reichenbach J, &, Zychlinsky A, (2010) Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 116, 1570-1573.